Innovation
11 patent families — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace accelerating. Cited 600 times.
| Year | Filings |
|---|---|
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 4 |
| 2024 | 4 |
| 2025 | 8 |
| 2026 | 6 |
Social engagement
Social engagement: 14.5K social following, 9 posts in the last 12 months — above the industry median.
Investor mix
17 investors on record; lead investors include BioMedPartners, Pureos Bioventures, Morningside, Jeito.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 9 | 53% |
| Private equity | 2 | 12% |
| Accelerator & incubator | 1 | 6% |
| Bank & private debt | 1 | 6% |
| Other / undisclosed | 4 | 24% |
Hiring activity
Hires periodically
5 roles tracked across 4 of the last 12 months
15 Jun 2026 · Clinical Supply Manager · Allschwil
16 Jan 2026 · Senior CMC Regulatory Affairs Manager · Allschwil
16 Jan 2026 · Director of CMC Operations · Allschwil
4 Dec 2025 · Associate Director/Director Procurement · Allschwil
24 Nov 2025 · Associate Director, Human Recources & Facilities · Allschwil
Based on job postings tracked across public sources.